These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32726229)

  • 1. The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department.
    Cole JB; Lee SC; Martel ML; Smith SW; Biros MH; Miner JR
    West J Emerg Med; 2020 Jul; 21(4):728-736. PubMed ID: 32726229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
    Nuttall GA; Eckerman KM; Jacob KA; Pawlaski EM; Wigersma SK; Marienau ME; Oliver WC; Narr BJ; Ackerman MJ
    Anesthesiology; 2007 Oct; 107(4):531-6. PubMed ID: 17893447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Droperidol, QT prolongation, and sudden death: what is the evidence?
    Kao LW; Kirk MA; Evers SJ; Rosenfeld SH
    Ann Emerg Med; 2003 Apr; 41(4):546-58. PubMed ID: 12658255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small doses of droperidol do not present relevant torsadogenic actions: a double-blind, ondansetron-controlled study.
    Tracz K; Owczuk R
    Br J Clin Pharmacol; 2015 Apr; 79(4):669-76. PubMed ID: 25293524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT prolongation, torsades des pointes, and cardiac arrest after 4 mg of IV ondansetron.
    Orozco BS; Lee SC; Fuchs RT; Fushianes GD; Cole JB
    Am J Emerg Med; 2023 Jun; 68():214.e3-214.e6. PubMed ID: 37085406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
    Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ
    Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
    Lawrence KR; Nasraway SA
    Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droperidol transiently prolongs the QT interval in children undergoing single ventricle palliation.
    Scott JP; Stuth EA; Stucke AG; Cava JR; Berens RJ
    Pediatr Cardiol; 2015 Jan; 36(1):196-204. PubMed ID: 25087057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency medicine updates: Droperidol.
    Cisewski D; Long B; Gottlieb M
    Am J Emerg Med; 2022 Mar; 53():180-184. PubMed ID: 35063889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized, intuitive & visual QT-prolongation monitoring using patient-specific QTc threshold with pseudo-coloring and explainable AI.
    Alahmadi A; Davies A; Vigo M; Jay C
    J Electrocardiol; 2023; 81():218-223. PubMed ID: 37837739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
    Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
    Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol].
    Guy JM; André-Fouet X; Porte J; Bertrand M; Lamaud M; Verneyre H
    Ann Cardiol Angeiol (Paris); 1991 Nov; 40(9):541-5. PubMed ID: 1776799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?
    Romero J; Baldinger SH; Goodman-Meza D; Engstrom K; Valencia CR; Golive A; Medrano F; Rangasamy S; Makkiya M; Fisher JD; Gross J; Krumerman A; Kim S; Garcia MJ; Di Biase L; Ferrick KJ
    J Interv Card Electrophysiol; 2016 Jan; 45(1):37-45. PubMed ID: 26589717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients.
    Al-Azayzih A; Al-Qerem W; Al-Azzam S; Muflih S; Al-Husein BA; Kharaba Z; Kanaan RJ; Rahhal D
    Vasc Health Risk Manag; 2024; 20():27-37. PubMed ID: 38318252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of droperidol and haloperidol for use by paramedics: assessment of safety and effectiveness.
    Macht M; Mull AC; McVaney KE; Caruso EH; Johnston JB; Gaither JB; Shupp AM; Marquez KD; Haukoos JS; Colwell CB
    Prehosp Emerg Care; 2014; 18(3):375-80. PubMed ID: 24460451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D
    J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram.
    Chan A; Isbister GK; Kirkpatrick CM; Dufful SB
    QJM; 2007 Oct; 100(10):609-15. PubMed ID: 17881416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.
    Tisdale JE; Rasty S; Padhi ID; Sharma ND; Rosman H
    J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.